Regencell Bioscience (RGC) has had the highest return since January 1, 2025 by a US stock with a market cap of $2B+, returning 9,697.9%.
| ASSET | % RETURN |
|---|---|
Regencell Bioscience (RGC) | 9,697.9% |
QMMM Holdings Limited Ordinary Shares (QMMM) | 9,155.81% |
Diginex Limited Ordinary Shares (DGNX) | 2,942.25% |
Abivax SA American Depositary Shares (ABVX) | 1,472.24% |
Cidara Therapeutics (CDTX) | 705.64% |
Sandisk (SNDK) | 598.6% |
Celcuity LLC (CELC) | 592.89% |
Anbio Biotechnology Class A Ordinary Shares (NNNN) | 403.99% |
Terns Pharmaceuticals (TERN) | 388.65% |
TMC the metals (TMC) | 375.44% |
IREN (IREN) | 373.81% |
Bloom Energy (BE) | 366.33% |
Opendoor Technologies (OPEN) | 362.77% |
GRAIL, LLC (GRAL) | 357.13% |
Oklo (OKLO) | 355.16% |
Cogent Biosciences (COGT) | 322.78% |
ViaSat (VSAT) | 300.8% |
Metsera, Inc Common Stock (MTSR) | 291.67% |
MP Materials (MP) | 269.15% |
Centrus Energy (LEU) | 264.45% |
Mineralys Therapeutics, Inc Common Stock (MLYS) | 251.91% |
AngloGold Ashanti (AU) | 251.13% |
Western Digital (WDC) | 238.87% |
Aris Mining (ARMN) | 229.58% |
DRDGOLD Limited ADR (DRD) | 224.59% |
